Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Carcinoma, Lobular × entrectinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Thyroid Cancer, Papillary 2 Sarcoma 2 Salivary Gland Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Sarcoma, Ewing 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Nephroma, Mesoblastic 1 Neoplasm Metastasis 1 Melanoma 1 Medulloblastoma 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Glioma 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Lobular 1 Breast Neoplasms 1

Interventions

Letrozole 2 palbociclib 1 entrectinib 1 Tamoxifen 1 Radiotherapy 1 Goserelin 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04551495 2024-12-04

ROSALINE

Jules Bordet Institute

Phase 2 Active not recruiting

Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡